Condition: Hip Osteoarthritis · Hip Arthritis · Knee Osteoarthritis · Sponsor: Ottawa Hospital Research Institute
A prospective, multi-center, double-arm, parallel, interventional, randomized, controlled clinical trial to assess the rate of periprosthetic joint infection (PJI) in patients undergoing primary total knee arthroplasty (TKA), total hip arthroplasty (THA) or hip resurfacing (HR) with XPERIENCE™ (XP) Advanced Surgical Irrigation versus dilute Betadine (DB).
This description comes directly from the study's public registry record.
Sanjula Costa · 613-737-8899 · scosta@ohri.ca
Always discuss trial participation with your own doctor first.
| University of British Columbia | Vancouver, British Columbia, Canada | Recruiting |
| London Health Sciences Center | London, Ontario, Canada | Recruiting |
| The Ottawa Hospital | Ottawa, Ontario, Canada | Recruiting |
| Humber River Health | Toronto, Ontario, Canada | Recruiting |
| St. Joseph's Health Centre | Toronto, Ontario, Canada | Recruiting |
| Hôpital Maisonneuve-Rosemont | Montreal, Quebec, Canada | Recruiting |
| Jewish General Hospital | Montreal, Quebec, Canada | Recruiting |
| CHU de Quebec-Université Laval | Québec, Quebec, Canada | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05543941